Fundz

Vektor Medical Secures $16 Million Series A Funding

PRIVATEFeb 05, 2024

Amount Raised

$16 Million

Round Type

Series A

San DiegoBiotechnologyHealthcareHealth CareArtificial IntelligenceMedicalMachine LearningHealth Diagnostics

Investors

TVM Capital Life ScienceSolas Bio Ventures

Description

Vektor Medical secured $16 million in Series A funding co-led by Solas BioVentures and TVM Capital Life Science. The funding will support the commercialization of vMap®, Vektor’s AI-based arrhythmia analysis tool, and the expansion of clinical support and additional clinical studies.

Quick answer

Vektor Medical raised $16 Million in a Series A round, dated February 5, 2024. Investors: TVM Capital Life Science and Solas Bio Ventures. Vektor Medical is based in San Diego, California, United States.

How much did Vektor Medical raise?
Vektor Medical raised $16 Million in a Series A round on February 5, 2024.
Who invested in Vektor Medical?
TVM Capital Life Science and Solas Bio Ventures are named as investors in this round.
What does Vektor Medical do?
Vektor Medical is a pioneer in non-invasive, AI-based arrhythmia analysis technology, aiming to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias.
Where is Vektor Medical based and how big is it?
Vektor Medical is based in San Diego, California, United States. Fundz records about 42 employees.
Who are the decision-makers at Vektor Medical?
Fundz holds 1 contact at Vektor Medical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as Vektor Medical that raised within 45 days of this round, from Fundz verified event records.

  • Nabla raised $24M (Series B) on January 5, 2024.
  • Spectral AI raised $1M (Seed) on March 20, 2024.
  • Actnova raised $2.7M (Pre-Series A) on February 29, 2024.
  • Tenon Medical raised $2.6M (Seed) on February 20, 2024.
  • Greenbrook TMS raised $2.5M (Seed) on February 15, 2024.
  • Actnova raised $2.4M (Pre-Series A) on February 7, 2024.

Who to call at Vektor Medical, and when

A new round usually means Vektor Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vektor Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vektor Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vektor Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vektor Medical

Location

San Diego, California, United States

About

Vektor Medical is a pioneer in non-invasive, AI-based arrhythmia analysis technology, aiming to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Their flagship product, vMap, is an AI-based, non-invasive arrhythmia analysis tool designed to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vektor Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts9 people are listed at Vektor Medical. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vektor Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Vektor Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.